Teresa Puig
- Virology top 1%
- HIV Research and Treatment 20
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 22
- Oncology top 5%
- Cancer Cells and Metastasis 8
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 20
- HIV/AIDS Research and Interventions 12
- Biomaterials top 5%
- Electrospun Nanofibers in Biomedical Applications 12
-
- Peroxisome Proliferator-Activated Receptors 10
-
- 3D Printing in Biomedical Research 9
- Co-authors
- Joaquim CiuranaMarc RabionetSònia PalomerasRámón ColomerBonaventura ClotetGlòria OliverasJoana RelatAntonio J. Guerra
- Cited by
- VirologyCancer ResearchOncology
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Teresa Puig
113 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 126
- Virology 539
- Cancer Research 618
- Oncology 676
- Infectious Diseases 454
- Biomaterials 246
Countries citing papers authored by Teresa Puig
This map shows the geographic impact of Teresa Puig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teresa Puig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teresa Puig more than expected).
Fields of papers citing papers by Teresa Puig
This network shows the impact of papers produced by Teresa Puig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teresa Puig. The network helps show where Teresa Puig may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Teresa Puig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 8 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 15 | |
| 6 | 2021 | 7 | |
| 7 | 2019 | 50 | |
| 8 | 2018 | 27 | |
| 9 | 2017 | 72 | |
| 10 | 2016 | 76 | |
| 11 | 2015 | 54 | |
| 12 | 2010 | 27 | |
| 13 | 2010 | 26 | |
| 14 | 2009 | 83 | |
| 15 | 2008 | 6 | |
| 16 | 2007 | 39 | |
| 17 | Fatty acid metabolism in cancer cells: Differential inhibitory effects of epigallocatechin (EGCG) and C75 | 2006 | 2 |
| 18 | 2005 | 3 | |
| 19 | 2004 | 26 | |
| 20 | 1998 | 20 |
About Teresa Puig
Teresa Puig is a scholar working on Virology, Cancer Research and Infectious Diseases, having authored 115 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (22 papers), HIV Research and Treatment (20 papers), HIV/AIDS drug development and treatment (20 papers), Electrospun Nanofibers in Biomedical Applications (12 papers), HIV/AIDS Research and Interventions (12 papers), Peroxisome Proliferator-Activated Receptors (10 papers), 3D Printing in Biomedical Research (9 papers) and Cancer Cells and Metastasis (8 papers). The work is most often cited by research in Virology (539 citations), Cancer Research (618 citations) and Oncology (676 citations). Teresa Puig has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Joaquim Ciurana, Marc Rabionet, Sònia Palomeras, Rámón Colomer, Bonaventura Clotet, Glòria Oliveras, Joana Relat, Antonio J. Guerra, Lı́dia Ruiz and Pedro F. Marrero. Their work appears in journals such as Blood, PLoS ONE and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.